According to estimates from foreign experts, 350 million people worldwide are affected by some form of gout. What constitutes painful swelling and joint stiffness is gout.

Symptoms of arthritis include pain, stiffness, and swelling, as well as the affected joint ( s ) being a different color than usual. Additionally, the affected joint( s ) may not be able to move or stretch as much as it once did.

Experts in the UK recently conducted a study to examine cannabis usage by arthritic sufferers. More details about the study’s findings can be found below thanks to a NORML press transfer:

London, United Kingdom: People with inflammatory arthritis record reduced pain and sustained improvements in their health-related quality of life following their use of medical cannabis procedures, according to empirical information published in the journal International Clinical Psychopharmacology.

In 82 patients who were enrolled in the UK Medical Cannabis Registry, British researchers evaluated the use of cannabis-based medicinal products ( CBMPs ) made of either flower or oil extracts. American doctors have been permitted to prescribe cannabis-based medications to people who are not taking traditional medicines since 2018. Scientists assessed changes in patient-reported results actions at one, three, six, and 12 weeks.

People constantly reported improvements in stress, pain, and nap during the length of the research

The study’s authors came to the conclusion that” this study demonstrated an associated improvement in pain intensity and other relevant result in people who have been given CBMPs for chronic pain afflicted by inflammatory arthritis. In contrast, CBMPs were generally well tolerated by the majority of people. The results further support for continued evaluation of CBMPs in this setting. [ T]hese results

Another observational studies assessing the use of hemp products in clients enrolled in the UK Cannabis Registry have reported them to be effective for those suffering from chronic pain, stress, post-traumatic anxiety, depression, head, multiple sclerosis, osteoarthritis, inflammatory bowel disease, and other maladies.

Full text of the study,” Assessment of clinical outcomes in patients with inflammatory arthritis: Analysis from the UK Medical Cannabis Registry”, appears in the International Clinical Psychopharmacology. Additional information on cannabis and arthritis is available from NORM L’s publication, Clinical Applications for Cannabis &amp, Cannabinoids.

This article first appeared on Internationalcbc.com and is syndicated here with special permission.

Photo by Towfiqu barbhuiya on Unsplash

Skip to content